Satisfaction with Care in Late Stage Parkinson’s Disease

Rosqvist, Kristina; Hagell, Peter; Iwarsson, Susanne; Nilsson, Maria H; Odin, Per

doi:https://doi.org/10.1155/2019/2593547

Parkinson’s Disease

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2019 | Article ID 2593547 | https://doi.org/10.1155/2019/2593547

Satisfaction with Care in Late Stage Parkinson’s Disease

Kristina Rosqvist,¹Peter Hagell,²Susanne Iwarsson,³Maria H Nilsson,^3,4and Per Odin^1,5

Academic Editor: Karsten Witt

Received30 Jan 2019

Revised10 May 2019

Accepted19 May 2019

Published09 Jun 2019

Abstract

In late stage Parkinson’s disease (PD) (i.e., Hoehn and Yahr (HY) stages IV-V), both motor and nonmotor symptoms (NMS) are pronounced, and the patients become increasingly dependent on help in their daily life. Consequently, there is an increasing demand on health-care and social care resources for these patients and support for their informal caregivers. The aim of this study was to assess satisfaction with care in late stage PD patients and to identify factors associated with satisfaction with care. Moreover, to assess their informal caregivers’ satisfaction with support and to identify factors associated with caregivers’ satisfaction with support. Factors potentially associated with satisfaction with care/support were assessed in 107 late stage PD patients and their informal caregivers () and entered into multivariable logistic regression analyses. Fifty-eight (59%) of the patients and 45 (59%) of the informal caregivers reported satisfaction with their overall care/support. Patients satisfied with their care reported higher independence in activities of daily living (ADL) (Katz ADL index; ), less depressive symptoms (Geriatric Depression Scale, GDS-30; ), and higher individual quality of life (QoL) (Schedule for the Evaluation of Individual Quality of Life Questionnaire, SEIQoL-Q; ). Multivariable logistic regression analyses identified depressive symptoms () and independence in ADL () as independently associated with satisfaction with care. For informal caregivers, the analyses identified patients’ HY stage () and caregivers’ QoL (Alzheimer’s Carers Quality of Life Inventory, ACQLI; ) as independently associated with satisfaction with caregiver support. The results indicate that an effective both pharmacological and nonpharmacological PD therapy is important, to adequately treat motor and NMS (e.g., depressive symptoms) in order to improve depressive symptoms and patient independence in ADL. This may benefit not only the patients, but also their informal caregivers.

1. Introduction

In the late and most severe stage of Parkinson’s disease (PD), i.e., Hoehn and Yahr (HY) stages IV-V [1], both motor and nonmotor symptoms (NMS) are pronounced [2–4], and the patients become increasingly dependent on help from others in their daily life [1, 5].

Late stage PD has been estimated to constitute about 15–20% of the PD population [6], which prevalence is expected to increase due to increased longevity and improved health care [5, 7, 8]. Moreover, as PD is a progressive disease, the burden on informal/family caregivers is likely to increase during the late stage of the disease [9]. Consequently, there is an increasing demand on health-care and social care resources for these patients and support for their informal/family caregivers [10].

Previous research has shown that PD causes a great burden for the patients’ family caregivers, which affects their own physical health, relationships, and mood [11]. It is essential to recognize and manage caregiver burden, for the well being of both the patient and the family caregiver, as failure to do so may lead to exhaustion for the caregiver and premature institutionalization for the patient [9].

There is a growing focus on patient-centered health care, which includes taking into consideration experiences of patients and their informal caregivers when it comes to satisfaction with the care and support they receive [12]. However, there is limited knowledge on which factors are associated with satisfaction with care in PD in general [13] and especially in late stage PD. An increased knowledge regarding factors associated with satisfaction with care and support in late stage PD could serve as an important base for optimizing health and social care for this patient group.

The aim of this study was to describe and assess satisfaction with care in a sample of patients with late stage PD in Sweden and to identify factors associated with patient satisfaction with care as well as to describe and assess their informal caregivers’ satisfaction with support and to identify factors associated with caregivers’ satisfaction with support.

2. Material and Methods

2.1. Participants and Recruitment

Participants were recruited from the southern region of Sweden through neurology departments and the municipality-based health-care system. A total of 166 individuals were identified for the study and were contacted by post (through their treating physicians) and then by telephone. In most cases, the contact was made through an informal caregiver or nursing home/health-care personnel. Out of these, 53 declined, and six were noneligible.

Inclusion criteria were HY stages IV and V in “on” and/or having a substantial need of help with ADL (defined here as ≤ 50% on the Schwab and England Scale) [14], as well as having been diagnosed with idiopathic PD for a minimum of seven years. Exclusion criteria were cognitive symptoms that started before the PD diagnosis as well as symptomatic Parkinsonism (such as drug-induced Parkinsonism or normal pressure hydrocephalus). The present study was a Swedish substudy of the European multicenter project Care for Late Stage Parkinsonism (CLaSP) [15], where additional assessments were carried out at the Lund center, Sweden.

The study was approved by the Regional Ethical Review Board in Lund, Sweden (JPND HC-559-002). Written informed consent was obtained by the participants.

2.2. Procedure and Clinical Evaluation

Clinical assessments were made, and questionnaires were answered by patients and their informal family caregiver, if such a person existed and was available, during home visits. A number of self-administered rating scales for patients and informal caregivers were sent by post beforehand as well as returned by post afterwards. Any questions regarding the questionnaires were answered by the person making the assessments at the time of the home visit. All assessments were carried out during a time of the day when the patient normally was doing his/her best.

Independence in activities of daily living (ADL) was assessed by the Katz ADL index [16] (score range 0–6, 6 = independence, higher = better). Motor function was assessed by the motor section of the Unified PD Rating Scale (UPDRS; part III, score range 0–108, higher = worse) [17]. Nonmotor symptomatology was assessed by the NMS Scale (NMSS; score range 0–360, higher = worse) [18]. Cognitive function was assessed by the Mini-Mental State Examination (MMSE, score range 0–30, higher = better) [19], where a score ≥ 24 was regarded as normal [20]. Depressive symptoms were assessed with the Geriatric Depression Scale (GDS-30; score range 0–30, higher = worse) [21]. Cut-off for screening of depression (scores ≥10) has been validated for PD [22]. Generic health status was assessed by the EuroQol 5 Dimensions (EQ-5D-3 L; score range 0-1, higher = better) and visual analogue scale (score range 0–100, higher = better) [23, 24]. Individual QoL was assessed by the Schedule for the Evaluation of Individual QoL Questionnaire (SEIQoL-Q; score range 0–100, higher = better), which was translated from German to Swedish through validated forward-back translation [25]. Self-rated health status was assessed by the Nottingham Health Profile (NHP), which consists of six sections: emotional reactions, sleep, energy, pain, physical mobility, and social isolation (each section score range 0–100, higher = worse) [26–28]. Each section score was for the simple and multivariable logistic regression analyses dichotomized as better (0 = 0–50) and worse (1 = 51–100). Life satisfaction was assessed by the Life Satisfaction Questionnaire (LiSat-11; each item score range 1–6, higher = better) [29]; for the simple and multivariable logistic regression analyses, the item responses were dichotomized as not satisfied (0 = from very dissatisfied to rather satisfied; i.e., scores 1–4) and satisfied (1 = satisfied and very satisfied; i.e., scores 5-6). This dichotomization has previously been used by the developers of the instrument [29] as well as in previous PD research [30, 31]. Patient satisfaction with overall care and caregiver satisfaction with overall support were assessed by CLaSP [15] study-specific questions with five response categories: very satisfied, satisfied, neutral, unsatisfied, and very unsatisfied. The responses were dichotomized as satisfied (1 = very satisfied or satisfied) and not satisfied (0 = neutral, unsatisfied, or very unsatisfied) and used as the dependent variable. Caregiver QoL was assessed with Alzheimer’s Carers’ QoL Inventory (ACQLI; score range 0–30, higher = worse), which has been found useful also among caregivers in PD [32].

Complimentary information on whether the patient had been in contact with movement disorder specialist (MDS), PD-specialized nurse, or physiotherapist/occupational therapist/speech and language therapist during the past year was retrieved from the medical records. Data on whether the patients had professional home health care were collected from a study-specific questionnaire.

2.3. Statistical Analyses

Descriptive and clinical data are given by median and first and third quartiles (q1–q3) and frequencies and percentages, as appropriate. Differences were tested statistically with simple logistic regression analyses. values of <0.05 were considered significant. For the patients, ten independent variables with values <0.2 from the simple logistic regression analyses and two variables with values >0.2 that were considered clinically relevant were simultaneously entered into a multivariable logistic regression model. Two independent variables with were excluded: SEIQoL due to a high number of missing and EQ-5D VAS due to a high number of independent variables in relation to the number of participants, in order to keep the number of independent variables entered into the multivariable model limited. For informal caregivers, nine independent variables were entered into a multivariable logistic regression model. values were inspected, and the variable with the highest value was manually removed from the model through stepwise backward method, which was repeated until the remaining independent variables in the model had values <0.1. All analyses were performed using IBM SPSS version 24.0 (IBM 211 Corporation, Armonk, NY, USA).

3. Results

3.1. Demographic Data and Clinical Background Assessments

A total of 107 patients participated in this study, 62 (58%) of them were men. The median (q1–q3) age was 78 (73–84) years. Seventy-nine (74%) were in HY stage IV and 28 (26%) in stage V. Sixty-seven (62%) lived in ordinary housing and 40 (37%) in nursing home. The majority (; 83%) received professional home health care (Table 1).

The median (q1–q3) UPDRS III score was 40 (29–53). The median (q1–q3) NMSS score was 91 (55–128). The median (q1–q3) MMSE score was 22 (18–27). The median (q1–q3) GDS-30 score was 11 (8–16). Sixty-two (58%) of the participants reported depressive symptoms that were above the cut-off for screening of depression [22].

3.2. Satisfaction with Care and Informal Caregiver Support

Of the 99 (93%) individuals who had answered the question, 58 (59%) were satisfied with their care. Five of the eight participants who had not responded to this question had severe difficulties in participating and presented a more severe disease (50% were in HY V) with severe motor and nonmotor symptomatology and markedly worse cognitive impairment.

Regarding the patients’ informal caregivers, 45 (59%) of the 76 individuals who had responded to the question were satisfied with their support. Out of them, 57 (75%) were the spouse/partner, 18 (24%) were a son/daughter, and one was a sibling to the patient. In 27 (36%) cases out of the 76 replies from informal caregivers, both the patient and the informal caregiver had replied that they were satisfied with their care/support.

Comparisons between patients who were satisfied and patients who were not satisfied with their overall care indicated that those with higher satisfaction with care were more independent in ADL (), showed less depressive symptoms (), and rated their individual QoL better on the SEIQoL-Q (). For more detailed information, see Table 2.

Comparisons between caregivers who were satisfied and caregivers who were not satisfied with their overall support identified the following variables as statistically significant: patient age (), patient HY stage (), patient motor function (UPDRS III) (), and caregiver QoL (ACQLI) () (Table 3).

3.3. Multivariable Logistic Regression Analyses

The analyses identified depressive symptoms (), independence in ADL (), and satisfaction with somatic health (; i.e., not statistically significant) as independently associated with satisfaction with care. That is, depressive symptoms were negatively associated with satisfaction with care and independence in ADL, and satisfaction with somatic health were positively associated with satisfaction with care (Table 4). In a further step, age and gender were added to the final model. However, the final results remained identical, and age and gender were highly nonsignificant (age ; gender ).

A separate multivariable regression model was performed for informal caregiver data. The analyses identified patient HY stage () and caregiver QoL () as independently associated with satisfaction with caregiver support, where patient HY stage was positively associated with satisfaction with caregiver support (i.e., informal caregivers reported higher satisfaction with support when the patient was in HY stage V compared to stage IV) and caregiver QoL was negatively associated with satisfaction with caregiver support (i.e., informal caregivers reported lower satisfaction with support when rating lower QoL) (Table 5). When analyzing different clinical (patient) variables in relation to caregiver satisfaction, for patients who lived at home, no other differences were found between caregivers satisfied with their support and those who were not (Table 6).

4. Discussion

In this Swedish sample of patients in late stage PD, 59% reported satisfaction with their overall care and 59% of their informal caregivers reported satisfaction with their overall caregiver support. Depressive symptoms, independence in ADL, and satisfaction with somatic health were identified as factors associated with whether the patient was satisfied with his or her overall care. Patients’ HY stage and informal caregivers’ QoL were associated with informal caregivers’ satisfaction with support.

Surprisingly, none of the background variables such as age, gender, dwelling place, HY stage, or whether having a partner differed between the patients who were satisfied with their overall care and those who were not. This suggests that other factors may be more important for patients’ satisfaction with their overall care, such as the presence of depressive symptoms, independence in ADL, and satisfaction with somatic health. These findings are in line with the results of another PD study, where satisfaction with care did not differ based on demographic variables such as age, gender, education, or disease duration [13]. Similarly to our finding that 59% of the patients reported satisfaction with their overall care, the previous study found that 57% of their participants expressed satisfaction with their care [13].

Fatigue (NHP-energy) is a variable that was close to significant in the univariate analyses and that seemed to matter, coming close to significant also in the multivariable model on satisfaction with care. Another variable coming close to being presented in the multivariable model was satisfaction with life as a whole. These factors may also matter for patients’ satisfaction with care.

4.1. Depressive Symptoms

The results showed that depressive symptoms are one of the major factors negatively associated with satisfaction with care. Depressive symptoms have previously been identified as negatively associated with life satisfaction in late stage PD and as the strongest factor negatively associated with life satisfaction in all stages of PD [31]. As depressive symptoms are common in late stage PD [3, 5, 33, 34], it is important to identify and optimize treatment of depressive symptoms, not only to alleviate the symptoms per se, but also to enhance functional ability [35] and QoL [11, 36]. This may in turn lead to improved satisfaction with care.

Depressive symptoms in PD can be treated by antidepressive pharmacological treatment, i.e., serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and probably serotonin selective reuptake inhibitors (SSRIs) as well as through nonpharmacological interventions such as cognitive behavioural therapy [37] and exercise [38]. Optimizing dopaminergic treatment is also essential, as there is a dopaminergic response on NMS in late stage PD, with pronounced effects particularly on mood [3]. For those with nonmotor fluctuations or depressive symptoms occurring only in motor “off” state, this may be the preferred approach [39, 40].

4.2. Independence in ADL

In late stage PD, patients have pronounced motor and NMS and become increasingly dependent on help from others in their daily life, both when it comes to transfers and ADL [1, 5]. It is previously known that NMS such as depressive symptoms and cognitive impairment contribute to disability and worsened ADL function [35]. Independence in ADL may be improved and function maintained for longer through appropriate physiotherapy and occupational therapy training [41]. In order to reach increased independence in ADL, multiple actions are likely needed from both pharmacological and nonpharmacological approaches when it comes to therapy for both motor and NMS. This could mean that good availability of health care specialized on this patient group is needed. However, this needs to be further demonstrated in intervention studies.

The evidence for the benefit of PD team and PD team rehabilitation is not very strong generally. However, clinical experience supports the value of these, which is reflected in the consensus recommendations within the National Swedish Guidelines for PD [42]. Further, previous research has suggested higher overall satisfaction with care when patients were treated by PD specialists compared to general neurologists [12, 13].

4.3. Informal Caregivers

For the patients’ informal caregivers, the main results identified an association between patients’ HY stage and informal caregivers’ satisfaction with overall support, where the informal caregivers were more satisfied with their support when the patient was in the most severe stage of PD, i.e., HY stage V, as compared to stage IV. Moreover, for patients living at home, the informal caregivers still reported higher satisfaction with support when the patient was in HY stage V (Tables 5 and 6). An explanation to this could be a higher strain on informal caregivers when the patient is in stage IV compared to stage V, as all patients in stage V had home health care compared to 77% in stage IV. A second explanation could be that 61% of the patients in stage V lived in a nursing home, compared to 29% in stage IV. However, this is unlikely to be the main explanation, since the result was similar when analyzing the results of the participants living at home (Table 6). A third possible reason could be that patients in stage V are less mobile than those in stage IV, which in certain aspects could mean less strain on the informal caregiver, as patients in HY stage V are restricted to wheelchair or bed unless aided by another person [1], while in stage IV, the patient walks independently in spite of a severely disabling disease, which could mean severe balance impairment, freezing of gait, and falls [43, 44]. According to a previous study [9], the demands on the informal caregiver and the estimated cost of informal care are the highest when the patient is in stage IV, as in stage V, it is likely that many patients live in a nursing home.

In only 27 (36%) of the cases, the patient and the informal caregiver had both replied that they were satisfied with their overall care/support. This indicates that there might be a discrepancy between how patients and their informal caregivers, respectively, experience and perceive their situation.

4.4. Strengths, Limitations, and Further Perspectives

There are several limitations of this study. It is likely that other or additional factors may be associated with patients’ satisfaction with care as well as informal caregivers’ satisfaction with support, rather than the ones assessed in the present study. Given the current cross-sectional study design, it is not possible to draw casual conclusions. The symptomatology of late stage PD with increasing cognitive decline and problems in communicating may have affected the quality of the data collected for this study. However, a majority of the participants were able to complete most parts of the study without any apparent compromise in data quality.

The words “care” and “support” were not further defined and could have been interpreted in various ways among the participants. “Overall care” could presumably mean different things, such as home health care or medical care. As a large proportion of the current sample received both home health care and medical care and the proportions of participants were quite evenly distributed between those who were satisfied and those who were not satisfied, the interpretation of the words “care” and “support” would probably not matter for the outcome of this study. Similarly, the word “support” could theoretically mean both emotional/psychological and practical assistance from the health-care system.

A major strength of the present study is that we were able to recruit and assess a relatively large sample of patients in the late and most severe stages of PD, an area where knowledge presently is limited [33]. Future studies on satisfaction with care could further investigate and distinguish between different areas of care instead of focusing on a perception of overall care. Qualitative research methodology may give an insight into which specific areas are important for patient satisfaction with care and informal caregiver satisfaction with support in late stage PD. Availability of health-care and social resources is likely to influence satisfaction with care and support. The results of this study should be replicated in other national contexts, as the current study was carried out in a setting with the Swedish health and social care systems. Moreover, international comparisons would be of value.

5. Conclusions

Patient satisfaction with care in late stage PD appears to be negatively associated with depressive symptoms and positively associated with independence in ADL. Satisfaction with somatic health also appears to be of importance for patient satisfaction with care. In addition, late stage patients’ informal caregivers’ satisfaction with support appears positively associated with patients’ HY stage and negatively associated with informal caregivers’ QoL.

A multidisciplinary approach to the management of late stage PD patients and their family caregivers should probably have high priority in order to provide an effective symptomatic pharmacological and nonpharmacological PD therapy, to identify and adequately treat motor and NMS (e.g., depressive symptoms), and to offer possibilities for optimal training (e.g., in ADL) in order to optimize management and coping of daily activities. This may benefit not only patients in late stage PD, but also their family caregivers.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors have no conflicts of interest to report.

Acknowledgments

The authors would like to acknowledge the CLaSP consortium. The main funding of this project was a JPND grant provided by the Swedish Research Council (VR), CLaSP/JPND HC-559-002. This study was also funded by MultiPark, the strategic research area for neuroscience at Lund University; the Swedish Parkinson Foundation; the Swedish Parkinson Academy; and the Faculty of Medicine at Lund University.

References

M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression, and mortality,” Neurology, vol. 17, no. 5, p. 427, 1967.
View at: Publisher Site | Google Scholar
K. Rosqvist, M. Horne, P. Hagell, S. Iwarsson, M. H. Nilsson, and P. Odin, “Levodopa effect and motor function in late stage Parkinson’s disease,” Journal of Parkinson’s Disease, vol. 8, no. 1, pp. 59–70, 2018.
View at: Publisher Site | Google Scholar
K. Rosqvist, P. Odin, P. Hagell, S. Iwarsson, M. H. Nilsson, and A. Storch, “Dopaminergic effect on non-motor symptoms in late stage Parkinson’s disease,” Journal of Parkinson’s Disease, vol. 8, no. 3, pp. 409–420, 2018.
View at: Publisher Site | Google Scholar
N. J. Weerkamp, G. Tissingh, P. J. E. Poels et al., “Nonmotor symptoms in nursing home residents with Parkinson’s disease: prevalence and effect on quality of life,” Journal of the American Geriatrics Society, vol. 61, no. 10, pp. 1714–1721, 2013.
View at: Publisher Site | Google Scholar
M. Coelho and J. J. Ferreira, “Late-stage Parkinson disease,” Nature Reviews Neurology, vol. 8, no. 8, pp. 435–442, 2012.
View at: Publisher Site | Google Scholar
D. Enders, M. Balzer-Geldsetzer, O. Riedel et al., “Prevalence, duration and severity of Parkinson’s disease in Germany: a combined meta-analysis from literature data and outpatient samples,” European Neurology, vol. 78, no. 3-4, pp. 128–136, 2017.
View at: Publisher Site | Google Scholar
J.-P. Bach, U. Ziegler, G. Deuschl, R. Dodel, and G. Doblhammer-Reiter, “Projected numbers of people with movement disorders in the years 2030 and 2050,” Movement Disorders, vol. 26, no. 12, pp. 2286–2290, 2011.
View at: Publisher Site | Google Scholar
E. R. Dorsey, R. Constantinescu, J. P. Thompson et al., “Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030,” Neurology, vol. 68, no. 5, pp. 384–386, 2007.
View at: Publisher Site | Google Scholar
P. E. Mosley, R. Moodie, and N. Dissanayaka, “Caregiver burden in Parkinson disease: a critical review of recent literature,” Journal of Geriatric Psychiatry and Neurology, vol. 30, no. 5, pp. 235–252, 2017.
View at: Publisher Site | Google Scholar
T. E. Page, N. Farina, A. Brown et al., “Instruments measuring the disease-specific quality of life of family carers of people with neurodegenerative diseases: a systematic review,” BMJ Open, vol. 7, Article ID e013611, 2017.
View at: Publisher Site | Google Scholar
A. Schrag, A. Hovris, D. Morley, N. Quinn, and M. Jahanshahi, “Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability,” Parkinsonism & Related Disorders, vol. 12, no. 1, pp. 35–41, 2006.
View at: Publisher Site | Google Scholar
A. Schrag, K. Khan, S. Hotham, R. Merritt, O. Rascol, and L. Graham, “Experience of care for Parkinson’s disease in european countries: a survey by the european Parkinson’s disease association,” European Journal of Neurology, vol. 25, no. 12, pp. 1410–e120, 2018.
View at: Publisher Site | Google Scholar
E. R. Dorsey, T. S. Voss, D. R. Shprecher et al., “A U.S. survey of patients with Parkinson’s disease: satisfaction with medical care and support groups,” Movement Disorders, vol. 25, no. 13, pp. 2128–2135, 2010.
View at: Publisher Site | Google Scholar
R. Schwab and A. England, “Projection technique for evaluating surgery in Parkinson’s disease,” in Proceedings of the Third Symposium on Parkinson’s Disease, F. J. Gillingham and M. C. Donaldson, Eds., pp. 152–157, Edinburgh, Scotland, 1969.
View at: Google Scholar
M. Balzer-Geldsetzer, J. Ferreira, P. Odin et al., “Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study,” BMC Neurology, vol. 18, p. 185, 2018.
View at: Publisher Site | Google Scholar
S. Katz, A. B. Ford, R. W. Moskowitz, B. A. Jackson, and M. W. Jaffe, “Studies of illness in the aged,” JAMA, vol. 185, no. 12, pp. 914–919, 1963.
View at: Publisher Site | Google Scholar
S. Fahn, R. L. Elton, and Members of the UPDRS Development Committee, “Unified Parkinson’s disease rating scale,” in Recent Developments in Parkinson’s Disease, S. Fahn, C. Marsden, D. Calne, and M. Goldstein, Eds., vol. 2, pp. 153–163, MacMillan, Healthcare Information FP, Trenton, NJ, USA, 1987.
View at: Google Scholar
K. R. Chaudhuri, P. Martinez-Martin, R. G. Brown et al., “The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study,” Movement Disorders, vol. 22, no. 13, pp. 1901–1911, 2007.
View at: Publisher Site | Google Scholar
M. F. Folstein, S. E. Folstein, and P. R. McHugh, “Mini-mental state,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975.
View at: Publisher Site | Google Scholar
J. P. Dick, R. J. Guiloff, A. Stewart et al., “Mini-mental state examination in neurological patients,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 47, no. 5, pp. 496–499, 1984.
View at: Publisher Site | Google Scholar
J. A. Yesavage, T. L. Brink, T. L. Rose et al., “Development and validation of a geriatric depression screening scale: a preliminary report,” Journal of Psychiatric Research, vol. 17, no. 1, pp. 37–49, 1982.
View at: Publisher Site | Google Scholar
W. M. McDonald, P. E. Holtzheimer, M. Haber, J. L. Vitek, K. McWhorter, and M. Delong, “Validity of the 30-item geriatric depression scale in patients with Parkinson’s disease,” Movement Disorders, vol. 21, no. 10, pp. 1618–1622, 2006.
View at: Publisher Site | Google Scholar
A. Schrag, C. Selai, M. Jahanshahi, and N. P. Quinn, “The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 69, no. 1, pp. 67–73, 2000.
View at: Publisher Site | Google Scholar
EQ-5D-3L, The EuroQol Group, https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/.
G. Becker, C. S. Merk, C. Meffert, and F. Momm, “Measuring individual quality of life in patients receiving radiation therapy: the SEIQoL-Questionnaire,” Quality of Life Research, vol. 23, no. 7, pp. 2025–2030, 2014.
View at: Publisher Site | Google Scholar
S. M. Hunt, J. McEwen, and S. P. McKenna, “Measuring health status: a new tool for clinicians and epidemiologists,” Journal of the Royal College of General Practitioners, vol. 35, pp. 185–188, 1985.
View at: Google Scholar
I. Wiklund, B. Romanus, and S. M. Hunt, “Self-assessed disability in patients with arthrosis of the hip joint: reliability of the Swedish version of the Nottingham health profile,” International Disability Studies, vol. 10, no. 4, pp. 159–163, 1988.
View at: Publisher Site | Google Scholar
P. Hagell, D. Whalley, S. P. McKenna, and O. Lindvall, “Health status measurement in Parkinson’s disease: validity of the PDQ-39 and Nottingham health profile,” Movement Disorders, vol. 18, no. 7, pp. 773–783, 2003.
View at: Publisher Site | Google Scholar
A. R. Fugl-Meyer, R. Melin, and K. S. Fugl-Meyer, “Life satisfaction in 18- to 64-year-old Swedes: in relation to gender, age, partner and immigrant status,” Journal of Rehabilitation Medicine, vol. 34, no. 5, pp. 239–246, 2002.
View at: Publisher Site | Google Scholar
H. Gustafsson, P. Nordström, S. Stråhle, and A. Nordström, “Parkinson’s disease: a population-based investigation of life satisfaction and employment,” Journal of Rehabilitation Medicine, vol. 47, no. 1, pp. 45–51, 2015.
View at: Publisher Site | Google Scholar
K. Rosqvist, P. Hagell, P. Odin, H. Ekström, S. Iwarsson, and M. H. Nilsson, “Factors associated with life satisfaction in Parkinson’s disease,” Acta Neurologica Scandinavica, vol. 136, no. 1, pp. 64–71, 2017.
View at: Publisher Site | Google Scholar
P. Hagell and S. Smith, “A psychometric comparison of two carer quality of life questionnaires in Huntington’s disease: implications for neurodegenerative disorders,” Journal of Huntington’s Disease, vol. 2, pp. 315–322, 2013.
View at: Publisher Site | Google Scholar
M. Coelho, M. J. Marti, E. Tolosa et al., “Late-stage Parkinson’s disease: the barcelona and lisbon cohort,” Journal of Neurology, vol. 257, no. 9, pp. 1524–1532, 2010.
View at: Publisher Site | Google Scholar
M. Fabbri, M. Coelho, L. C. Guedes et al., “Response of non-motor symptoms to levodopa in late-stage Parkinson’s disease: results of a levodopa challenge test,” Parkinsonism & Related Disorders, vol. 39, pp. 37–43, 2017.
View at: Publisher Site | Google Scholar
D. Weintraub, P. J. Moberg, J. E. Duda, I. R. Katz, and M. B. Stern, “Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease,” Journal of the American Geriatrics Society, vol. 52, no. 5, pp. 784–788, 2004.
View at: Publisher Site | Google Scholar
S.-E. Soh, M. E. Morris, and J. L. McGinley, “Determinants of health-related quality of life in Parkinson’s disease: a systematic review,” Parkinsonism & Related Disorders, vol. 17, no. 1, pp. 1–9, 2011.
View at: Publisher Site | Google Scholar
L. Troeung, S. J. Egan, and N. Gasson, “A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease,” PLoS One, vol. 8, Article ID e79510, 2013.
View at: Publisher Site | Google Scholar
G. O. Reynolds, M. W. Otto, T. D. Ellis, and A. Cronin-Golomb, “The therapeutic potential of exercise to improve mood, cognition, and sleep in Parkinson’s disease,” Movement Disorders, vol. 31, no. 1, pp. 23–38, 2016.
View at: Publisher Site | Google Scholar
C. Mueller, A. P. Rajkumar, Y. M. Wan et al., “Assessment and management of neuropsychiatric symptoms in Parkinson’s disease,” CNS Drugs, vol. 32, no. 7, pp. 621–635, 2018.
View at: Publisher Site | Google Scholar
J. Classen, J. Koschel, C. Oehlwein et al., “Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues,” Journal of Neural Transmission, vol. 124, no. 8, pp. 1029–1036, 2017.
View at: Publisher Site | Google Scholar
S. Varanese, Z. Birnbaum, R. Rossi, and A. Di Rocco, “Treatment of advanced Parkinson’s disease,” Parkinson’s Disease, vol. 2010, p. 480260, 2011.
View at: Publisher Site | Google Scholar
The National Swedish Guidelines for PD, Board of Health and Welfare, https://www.socialstyrelsen.se/SiteCollectionDocuments/2016-12-1-Kunskapsunderlag-PD.pdf.
B. R. Bloem, J. M. Hausdorff, J. E. Visser, and N. Giladi, “Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena,” Movement Disorders, vol. 19, no. 8, pp. 871–884, 2004.
View at: Publisher Site | Google Scholar
Y. Okuma, “Freezing of gait and falls in Parkinson’s disease,” Journal of Parkinson’s Disease, vol. 4, pp. 255–260, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Kristina Rosqvist et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1631

Downloads

1118

Citations